CompletedNot Applicable

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer

France22 participantsStarted 2015-09

Plain-language summary

The purpose of this study is to compare, for each patient, dosimetry of organs at risk (bladder, rectum, sigmoid, small bowel) in two bladder distension procedures (emptied by a urinary catheter or filled with 120cc) during PDR 3D image-guided brachytherapy of cervical cancer.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> or = 18 years old * with a cervical cancer histologically proven (squamous cell carcinoma, adenocarcinoma and neuroendocrine cell carcinoma) * Utero-vaginal brachytherapy indications:: * Stage 1B1: brachytherapy before surgery * Stages IB2 to IIIB: after pelvic radiotherapy (45Gy/25 fractions/5 weeks) with or without concomitant chemotherapy * Ability to provide an informed written consent form * Patient must be affiliated to a social security system Exclusion Criteria: * Age \< 18 years old * History of pelvic radiotherapy * History of pelvic surgery * Recent joint prothesis (\<3 months) * Pregnant woman or being breastfeeding * Patients deprived of liberty or under supervision

What they're measuring

Demonstrate the non inferiority of 3D image-guided brachytherapy with emptied bladder compared to filled bladder for the dose received by the bladder

Timeframe: 1 day

Trial details

NCT IDNCT02865837

SponsorInstitut de Cancérologie de Lorraine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-08

View on ClinicalTrials.gov More Cervical Cancer trials